Tower Research Capital LLC (TRC) - CEREVEL THERAPEUTICS HLDNG I ownership

CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 203 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2023. The put-call ratio across all filers is 1.16 and the average weighting 0.6%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q2 2024$1,352,887
+4296.3%
33,086
+4444.8%
0.02%
+2200.0%
Q1 2024$30,773
-86.8%
728
-86.7%
0.00%
-66.7%
Q4 2023$232,395
+662.1%
5,481
+292.3%
0.00%
+200.0%
Q3 2023$30,496
-77.5%
1,397
-67.2%
0.00%
-80.0%
Q2 2023$135,489
+208344.6%
4,262
+59.4%
0.01%
+150.0%
Q1 2023$65
-44.9%
2,674
-28.6%
0.00%
-60.0%
Q4 2022$118
-99.9%
3,747
-19.4%
0.01%
+150.0%
Q3 2022$131,000
-18.6%
4,649
-23.6%
0.00%
-50.0%
Q2 2022$161,000
-16.1%
6,084
+10.5%
0.00%
+100.0%
Q1 2022$192,000
+1.6%
5,506
-5.6%
0.00%
-33.3%
Q4 2021$189,000
-47.1%
5,830
-51.8%
0.00%
-66.7%
Q3 2021$357,000
+792.5%
12,093
+678.2%
0.01%
+800.0%
Q2 2021$40,000
+400.0%
1,554
+155.2%
0.00%
Q1 2021$8,000
+300.0%
609
+509.0%
0.00%
Q4 2020$2,0001000.00%
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q4 2023
NameSharesValueWeighting ↓
BAIN CAPITAL INVESTORS LLC 65,679,781$2,685,646,24557.02%
Twin Securities, Inc. 416,657$17,037,10513.40%
Sand Grove Capital Management LLP 919,023$37,578,85010.99%
Perceptive Advisors 10,794,876$441,402,48010.63%
P SCHOENFELD ASSET MANAGEMENT LP 796,440$32,566,4327.87%
ALPINE ASSOCIATES MANAGEMENT INC. 2,353,694$96,242,5474.60%
Avoro Capital Advisors LLC 7,539,547$308,292,0774.11%
Melqart Asset Management (UK) Ltd 1,099,229$44,947,4743.72%
Paradigm Biocapital Advisors LP 2,330,508$95,294,4723.65%
WATER ISLAND CAPITAL LLC 766,933$31,3603.33%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders